VIROVANCE Trademark

Trademark Overview

On Friday, July 11, 2025, a trademark application was filed for VIROVANCE with the United States Patent and Trademark Office. The USPTO has given the VIROVANCE trademark a serial number of 99278358. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, July 11, 2025. This trademark is owned by Virovance, Inc.. The VIROVANCE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological research and development in the field of oncology drug discovery using artificial intelligence; Providing AI-driven drug discovery services to third parties.
virovance

General Information

Serial Number99278358
Word MarkVIROVANCE
Filing DateFriday, July 11, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, July 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesScientific and technological research and development in the field of oncology drug discovery using artificial intelligence; Providing AI-driven drug discovery services to third parties.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 11, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVirovance, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Friday, July 11, 2025NEW APPLICATION ENTERED
Friday, July 11, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

virovance drug discovery providing intelligence driven services parties third artificial using